RCKT - Rocket Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RCKT is currently covered by 12 analysts with an average price target of $22.02. This is a potential upside of $18.08 (458.88%) from yesterday's end of day stock price of $3.94.

Rocket Pharmaceuticals's activity chart (see below) currently has 123 price targets and 124 ratings on display. The stock rating distribution of RCKT is 76.47% BUY and 23.53% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 23.62% with an average time for these price targets to be met of 112.21 days.

Highest price target for RCKT is $32, Lowest price target is $2.5, average price target is $10.28.

Most recent stock forecast was given by GEULAH LIVSHITS from CHARDAN CAPITAL on 13-Oct-2025. First documented stock forecast 19-Sep-2016.

Currently out of the existing stock ratings of RCKT, 26 are a BUY (76.47%), 8 are a HOLD (23.53%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$11

$7.15 (185.71%)

$11

14 days ago
(13-Oct-2025)

3/13 (23.08%)

$6.73 (157.61%)

140

Hold

$7

$3.15 (81.82%)

$8

25 days ago
(02-Oct-2025)

1/11 (9.09%)

$3.85 (122.22%)

374

Hold

$4

$0.15 (3.90%)

$9

3 months 3 days ago
(24-Jul-2025)

2/6 (33.33%)

$0.86 (27.39%)

113

Buy

$10

$6.15 (159.74%)

$11

3 months 3 days ago
(24-Jul-2025)

0/10 (0%)

$6.86 (218.47%)

Hold

3 months 4 days ago
(23-Jul-2025)

0/16 (0%)

$32.55 (344.44%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is RCKT (Rocket Pharmaceuticals) average time for price targets to be met?

On average it took 112.21 days on average for the stock forecasts to be realized with a an average price target met ratio 23.62

Which analyst has the current highest performing score on RCKT (Rocket Pharmaceuticals) with a proven track record?

ESTHER RAJAVELU

Which analyst has the most public recommendations on RCKT (Rocket Pharmaceuticals)?

Esther Rajavelu has 8 price targets and 3 ratings on RCKT

Which analyst is the currently most bullish on RCKT (Rocket Pharmaceuticals)?

Corey Davis with highest potential upside - $84.15

Which analyst is the currently most reserved on RCKT (Rocket Pharmaceuticals)?

Andrew Tsai with lowest potential downside - -$1.35

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?